Journal articles on the topic 'Vascular risk factors'

To see the other types of publications on this topic, follow the link: Vascular risk factors.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Vascular risk factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

de la Torre, Jack C. "Vascular Risk Factors." American Journal of Alzheimer's Disease & Other Dementiasr 28, no. 6 (June 28, 2013): 551–59. http://dx.doi.org/10.1177/1533317513494457.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hanyu, Haruo. "Treatment of vascular risk factors." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 49, no. 3 (2012): 284–87. http://dx.doi.org/10.3143/geriatrics.49.284.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ouldred, Emma, and Catherine Bryant. "Vascular risk factors and dementia." British Journal of Cardiac Nursing 5, no. 5 (May 2010): 240–46. http://dx.doi.org/10.12968/bjca.2010.5.5.47882.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

B??chetoille, Alain. "Vascular risk factors in glaucoma." Current Opinion in Ophthalmology 7, no. 2 (April 1996): 39–43. http://dx.doi.org/10.1097/00055735-199604000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tanaka, Yutaka, Hitoshi Hara, and Takenori Yamaguchi. "Risk factors of vascular dementia." Nosotchu 18, no. 4 (1996): 282–87. http://dx.doi.org/10.3995/jstroke.18.282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schmidt, R., H. Schmidt, and F. Fazekas. "Vascular risk factors in dementia." Journal of Neurology 247, no. 2 (February 21, 2000): 81–87. http://dx.doi.org/10.1007/s004150050021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Israelsson, Hanna, Bo Carlberg, Carsten Wikkelsö, Katarina Laurell, Babar Kahlon, Göran Leijon, Anders Eklund, and Jan Malm. "Vascular risk factors in INPH." Neurology 88, no. 6 (January 6, 2017): 577–85. http://dx.doi.org/10.1212/wnl.0000000000003583.

Full text
Abstract:
Objective:To assess the complete vascular risk factor (VRF) profile of idiopathic normal pressure hydrocephalus (INPH) using a large sample of representative patients with INPH and population-based controls to determine the extent to which vascular disease influences INPH pathophysiology.Methods:All patients with INPH who underwent shunting in Sweden in 2008–2010 were compared to age- and sex-matched population-based controls. Inclusion criteria were age 60–85 years and no dementia. The 10 most important VRFs and cerebrovascular and peripheral vascular disease were prospectively assessed using blood samples, clinical examinations, and standardized questionnaires. Assessed VRFs were hypertension, hyperlipidemia, diabetes, obesity, psychosocial factors, smoking habits, diet, alcohol intake, cardiac disease, and physical activity.Results:In total, 176 patients with INPH and 368 controls participated. Multivariable logistic regression analysis indicated that hyperlipidemia (odds ratio [OR] 2.380; 95% confidence interval [CI] 1.434–3.950), diabetes (OR 2.169; 95% CI 1.195–3.938), obesity (OR 5.428; 95% CI 2.502–11.772), and psychosocial factors (OR 5.343; 95% CI 3.219–8.868) were independently associated with INPH. Hypertension, physical inactivity, and cerebrovascular and peripheral vascular disease were also overrepresented in INPH. Moderate alcohol intake and physical activity were overrepresented among the controls. The population-attributable risk percentage was 24%.Conclusions:Our findings confirm that patients with INPH have more VRFs and lack the protective factors present in the general population. Almost 25% of cases of INPH may be explained by VRFs. This suggests that INPH may be a subtype of vascular dementia. Targeted interventions against modifiable VRFs are likely to have beneficial effects on INPH.
APA, Harvard, Vancouver, ISO, and other styles
8

Albu, Carmen, Vlad Padureanu, Mihail Boldeanu, Ana Bumbea, Anca Enescu, Dana Albulescu, Cristian Silosi, and Aurelia Enescu. "Vascular neurocognitive disorders and the vascular risk factors." Journal of Mind and Medical Sciences 5, no. 1 (April 1, 2018): 7–15. http://dx.doi.org/10.22543/7674.51.p715.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rao, Rahul. "Documentation of vascular risk factors in vascular dementia." Psychiatric Bulletin 22, no. 2 (February 1998): 97–99. http://dx.doi.org/10.1192/pb.22.2.97.

Full text
Abstract:
The diagnosis of vascular dementia may often be made on the basis of structural neuroimaging, this may not always be reliable. In view of this, a retrospective study of 30 case notes with diagnosis of vascular dementia was undertaken to examine the documentation of vascular risk factors and presence of cerebrovascular disease. Specific recommendations were then made for the future case note documentation. Nine months later, 10 case notes were examined to assess the impact of the recommendations. A noticeable improvement in the documentation of most risk factors was observed. The wider implications of these findings are discussed.
APA, Harvard, Vancouver, ISO, and other styles
10

BARBARASH, N. A., and D. Yu KUVSHINOV. "Smoking and cardio -vascular risk factors." Complex Issues of Cardiovascular Diseases, no. 1 (May 8, 2016): 51–54. http://dx.doi.org/10.17802/2306-1278-2016-1-51-54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Cechetto, David F., Vladimir Hachinski, and Shawn N. Whitehead. "Vascular risk factors and Alzheimer’s disease." Expert Review of Neurotherapeutics 8, no. 5 (May 2008): 743–50. http://dx.doi.org/10.1586/14737175.8.5.743.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Stewart, R., M. Prince, M. Richards, C. Brayne, and A. Mann. "Stroke, vascular risk factors and depression." British Journal of Psychiatry 178, no. 1 (January 2001): 23–28. http://dx.doi.org/10.1192/bjp.178.1.23.

Full text
Abstract:
BackgroundStroke, hypertension and diabetes are common in older Caribbean-born populations in the UK who may be at risk of depression secondary to vascular disease.AimsWe examined the association between stroke, vascular risk factors and depression in a community-based Caribbean-born population aged 55–75 years.MethodVascular risk factors were identified by interview, examination and blood tests. Depression was categorised using the Geriatric Depression Scale. Disablement was assessed as a potential mediating factor.ResultsPhysical illness and disablement were strongly associated with depression, independent of disablement. Previous stroke was associated with depression, independent of disablement. No vascular risk factors were associated with depression.ConclusionsThe risk of depression associated with stroke was not explained by disablement. However, the hypothesis that vascular risk factors are important in the genesis of depression was not supported.
APA, Harvard, Vancouver, ISO, and other styles
13

Fritze, J., B. Schneider, and M. Lanczik. "VASCULAR RISK FACTORS IN AFFECTIVE PSYCHOSES." Clinical Neuropharmacology 15 (1992): 182B. http://dx.doi.org/10.1097/00002826-199202001-00350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Moneta, G. L. "Vascular Risk Factors and Diabetic Neuropathy." Yearbook of Vascular Surgery 2006 (January 2006): 117–18. http://dx.doi.org/10.1016/s0749-4041(08)70101-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Downing, R. "Risk factors and major vascular surgery." Current Anaesthesia & Critical Care 2, no. 4 (October 1991): 203–7. http://dx.doi.org/10.1016/s0953-7112(05)80146-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Jefferson, Angela L. "Vascular Risk Factors and Midlife Cognition." Circulation 129, no. 15 (April 15, 2014): 1548–50. http://dx.doi.org/10.1161/circulationaha.114.008906.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Tesfaye, Solomon, Nish Chaturvedi, Simon E. M. Eaton, John D. Ward, Christos Manes, Constantin Ionescu-Tirgoviste, Daniel R. Witte, and John H. Fuller. "Vascular Risk Factors and Diabetic Neuropathy." New England Journal of Medicine 352, no. 4 (January 27, 2005): 341–50. http://dx.doi.org/10.1056/nejmoa032782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Carson, Culley C. "Vascular Risk Factors for Erectile Dysfunction." Journal of Urology 178, no. 6 (December 2007): 2250–51. http://dx.doi.org/10.1016/j.juro.2007.09.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Breteler, Monique M. B. "Vascular risk factors for Alzheimer’s disease:." Neurobiology of Aging 21, no. 2 (March 2000): 153–60. http://dx.doi.org/10.1016/s0197-4580(99)00110-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Verma, A. "Vascular Risk Factors and Diabetic Neuropathy." Yearbook of Neurology and Neurosurgery 2006 (January 2006): 47–48. http://dx.doi.org/10.1016/s0513-5117(08)70263-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Tesfaye, S., N. Chaturvedi, and S. E. Eaton. "Vascular risk factors and diabetic neuropathy." Journal of Vascular Surgery 41, no. 6 (June 2005): 1079. http://dx.doi.org/10.1016/j.jvs.2005.03.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Tziomalos, Konstantinos, Charitha N. Weerasinghe, Dimitri P. Mikhailidis, and Alexander M. Seifalian. "Vascular risk factors in South Asians." International Journal of Cardiology 128, no. 1 (August 2008): 5–16. http://dx.doi.org/10.1016/j.ijcard.2007.11.059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Chen, Neal X., and Sharon M. Moe. "Vascular Calcification: Pathophysiology and Risk Factors." Current Hypertension Reports 14, no. 3 (April 3, 2012): 228–37. http://dx.doi.org/10.1007/s11906-012-0265-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Debette, S. "Vascular risk factors and cognitive disorders." Revue Neurologique 169, no. 10 (October 2013): 757–64. http://dx.doi.org/10.1016/j.neurol.2013.07.022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Leahy, J. L. "Vascular Risk Factors and Diabetic Neuropathy." Yearbook of Endocrinology 2006 (January 2006): 85–87. http://dx.doi.org/10.1016/s0084-3741(08)70298-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Stewart, R., M. Prince, and Anthony Mann. "Vascular Risk Factors and Alzheimer's Disease." Australian & New Zealand Journal of Psychiatry 33, no. 6 (December 1999): 809–13. http://dx.doi.org/10.1046/j.1440-1614.1999.00657.x.

Full text
Abstract:
Objective: We aim to summarise the recent and accumulating epidemiological research which suggests that cardiovascular disease and vascular risk factors play an important role as risk factors for Alzheimer's disease (AD) in later life. Method: The epidemiological literature is summarised in considering the evidence for such an association, focusing on optimally designed population-based studies. Potential mechanisms of association are considered, drawing on relevant findings from neuroscience. Results: Cardiovascular disease and vascular risk disorders appear to be important factors in the aetiology of AD. However, there is a paucity of prospective studies with an adequate duration of follow-up to investigate the apparent age- and time-dependent nature of these associations. Conclusions: Vascular disorders represent potentially preventable risk factors with an important population impact due to their high prevalence in developed countries. The concept of AD and vascular dementia as clearly distinguishable disorders clinically or aetiologically is becoming increasingly tenuous. A better understanding of the relationship between AD and vascular disorders will depend on a more flexible diagnostic and conceptual framework.
APA, Harvard, Vancouver, ISO, and other styles
27

Sullivan, M. E., S. R. Keoghane, and M. A. W. Miller. "Vascular risk factors and erectile dysfunction." BJU International 87, no. 9 (June 2001): 838–45. http://dx.doi.org/10.1046/j.1464-410x.2001.02211.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Debette, S., and S. Seshadri. "Vascular risk factors and dementia revisited." Journal of Neurology, Neurosurgery & Psychiatry 80, no. 11 (October 28, 2009): 1183–84. http://dx.doi.org/10.1136/jnnp.2009.181289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Inzitari, D., F. Diaz, A. Fox, V. C. Hachinski, A. Steingart, C. Lau, A. Donald, J. Wade, H. Mulic, and H. Merskey. "Vascular Risk Factors and Leuko-Araiosis." Archives of Neurology 44, no. 1 (January 1, 1987): 42–47. http://dx.doi.org/10.1001/archneur.1987.00520130034014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Soret, Juliette, Dominique Debray, Flore Sicre de Fontbrune, Jean-Jacques Kiladjian, David Saadoun, Régis Peffault de Latour, Dominique Valla, et al. "Risk factors for vascular liver diseases." Clinics and Research in Hepatology and Gastroenterology 44, no. 4 (September 2020): 410–19. http://dx.doi.org/10.1016/j.clinre.2020.03.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Tesfaye, S., N. Chaturvedi, and S. E. M. Eaton. "Vascular risk factors and diabetic neuropathy." ACC Current Journal Review 14, no. 4 (April 2005): 20–21. http://dx.doi.org/10.1016/j.accreview.2005.02.082.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

CASSIDY, FREDERICK, and BERNARD J. CARROLL. "Vascular risk factors in late onset mania." Psychological Medicine 32, no. 2 (February 2002): 359–62. http://dx.doi.org/10.1017/s0033291701004718.

Full text
Abstract:
Background. Previous researches have suggested that late onset mania is a distinct subtype associated with medical and neurological disorders. Few studies, however, have focused on vascular risk factors.Methods. Records of 366 bipolar patients were reviewed and age of first psychiatric hospitalization determined. Late-onset cases were determined empirically from a distribution histogram. Late onset cases were matched to early onset cases and histories of vascular disease/risks and current cholesterol levels compared.Results. The distribution of age of first psychiatric hospitalization was bimodal with an intermode at age 47. Using that threshold, 6·3% of the cohort was classified as having late onset mania. Vascular risks factors were greater and current cholesterol levels higher in the late onset group.Conclusions. Late onset mania is associated with greater vascular risk factors. The bimodal appearance of age of first psychiatric hospitalization in this study provides further support of late onset mania as a distinct manic subtype with possibly a different, vascular aetiology. Control of these vascular risks may impact on the incidence of late onset mania, as well as on its clinical management.
APA, Harvard, Vancouver, ISO, and other styles
33

McCullagh, Catriona D., David Craig, Stephen P. McIlroy, and A. Peter Passmore. "Risk factors for dementia." Advances in Psychiatric Treatment 7, no. 1 (January 2001): 24–31. http://dx.doi.org/10.1192/apt.7.1.24.

Full text
Abstract:
There is little doubt that dementia is a very common cause of disability and dependency in our society. Since dementia of whatever type is usually more common with increasing age, then as population demographics change, so will the prevalence of dementia. Dementia is a generic term and the objective for clinicians, once dementia is suspected, is to attempt to define the cause. Alzheimer's disease is the most common cause of dementia, and in most centres vascular dementia would feature as the next most common aetiology. In some centres, Lewy body dementia is the second most common cause. Mixed Alzheimer's disease and vascular dementia would also feature high on the list at most centres.
APA, Harvard, Vancouver, ISO, and other styles
34

Terentes-Printzios, D., C. Vlachopoulos, P. Xaplanteris, N. Ioakeimidis, K. Aznaouridis, K. Baou, P. Pietri, D. Kardara, and C. Stefanadis. "P10.10 RISK FACTORS ACCELERATE VASCULAR AGING: RESULTS FROM THE CARDIOVASCULAR RISK FACTORS AFFECTING VASCULAR AGE (CRAVE) STUDY." Artery Research 8, no. 4 (2014): 159. http://dx.doi.org/10.1016/j.artres.2014.09.213.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Hayden, Kathleen M., Peter P. Zandi, Constantine G. Lyketsos, Ara S. Khachaturian, Lori A. Bastian, Gene Charoonruk, JoAnn T. Tschanz, et al. "Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia." Alzheimer Disease & Associated Disorders 20, no. 2 (April 2006): 93–100. http://dx.doi.org/10.1097/01.wad.0000213814.43047.86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Al-Bairmany, YaalaSaadyRaof, Noor Kasib Hadi, and Mays Alrubayi. "Incidence and risk factors for oxaliplatin-induced vascular pain during administration in Iraqi patients." Journal of Pharmacovigilance and Drug Research 3, no. 1 (March 1, 2022): 19–25. http://dx.doi.org/10.53411/jpadr.2022.3.1.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Manenti, Antonio, Maurizio Zizzo, Alberto Farinetti, and Luca Roncati. "Hepatico-jejunostomy: risk factors." International Surgery Journal 4, no. 3 (February 25, 2017): 1143. http://dx.doi.org/10.18203/2349-2902.isj20170882.

Full text
Abstract:
A scientific debate has been recently opened about the incidence of stricture after Roux-en-Y hepatico-jejunostomy (HJ). We consider this complication often related to previous inflammatory or vascular sufferings, which cause, at first, a biliary leak.
APA, Harvard, Vancouver, ISO, and other styles
38

Hanon, Olivier. "Vascular risk factors, cognitve decline, and dementia." Vascular Health and Risk Management Volume 4 (April 2008): 363–81. http://dx.doi.org/10.2147/vhrm.s1839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Knopman, David S., and Rosebud Roberts. "Vascular Risk Factors: Imaging and Neuropathologic Correlates." Journal of Alzheimer's Disease 20, no. 3 (May 26, 2010): 699–709. http://dx.doi.org/10.3233/jad-2010-091555.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Soto, Ileana, Mark P. Krebs, Alaina M. Reagan, and Gareth R. Howell. "Vascular Inflammation Risk Factors in Retinal Disease." Annual Review of Vision Science 5, no. 1 (September 15, 2019): 99–122. http://dx.doi.org/10.1146/annurev-vision-091517-034416.

Full text
Abstract:
Inflammation of the blood vessels that serve the central nervous system has been increasingly identified as an early and possibly initiating event among neurodegenerative conditions such as Alzheimer's disease and related dementias. However, the causal relevance of vascular inflammation to major retinal degenerative diseases is unresolved. Here, we describe how genetics, aging-associated changes, and environmental factors contribute to vascular inflammation in age-related macular degeneration, diabetic retinopathy, and glaucoma. We highlight the importance of mouse models in studying the underlying mechanisms and possible treatments for these diseases. We conclude that data support vascular inflammation playing a central if not primary role in retinal degenerative diseases, and this association should be a focus of future research.
APA, Harvard, Vancouver, ISO, and other styles
41

Martin, F. I. R. "Trends in risk factors for vascular disease." Medical Journal of Australia 150, no. 6 (March 1989): 348. http://dx.doi.org/10.5694/j.1326-5377.1989.tb136507.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Jamrozik, Konrad, and Richard Hockey. "Trends in risk factors for vascular disease." Medical Journal of Australia 150, no. 6 (March 1989): 348. http://dx.doi.org/10.5694/j.1326-5377.1989.tb136508.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Yanagi, Masahide, Ryo Kawasaki, Jie Jin Wang, Tien Y. Wong, Jonathan Crowston, and Yoshiaki Kiuchi. "Vascular risk factors in glaucoma: a review." Clinical & Experimental Ophthalmology 39, no. 3 (April 2011): 252–58. http://dx.doi.org/10.1111/j.1442-9071.2010.02455.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Breteler, Monique M. B., Michiel L. Bots, Alewijn Ott, and Albert Hofman. "Risk Factors for Vascular Disease and Dementia." Pathophysiology of Haemostasis and Thrombosis 28, no. 3-4 (1998): 167–73. http://dx.doi.org/10.1159/000022428.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Bhatia, M. S., and R. Chandra. "Vascular risk factors for stroke and depression." British Journal of Psychiatry 179, no. 5 (November 2001): 464–65. http://dx.doi.org/10.1192/bjp.179.5.464-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Kim, Dae Hyun. "TREATING VASCULAR RISK FACTORS IN ALZHEIMER'S DISEASE." Journal of the American Geriatrics Society 58, no. 1 (January 2010): 185–86. http://dx.doi.org/10.1111/j.1532-5415.2009.02637.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Mineva, Petya Pencheva. "Statins, vascular risk factors and stroke prevention." NATIONAL JOURNAL OF NEUROLOGY, no. 2 (January 19, 2019): 17–25. http://dx.doi.org/10.28942/nnj.v1i2.227.

Full text
Abstract:
The most widely prescribed drugs as a first-line therapy for dyslipidemia (DL) are 3-hydroxy-3-methylglutaryl-CoA inhibitors, also known as “statins”. They manifest direct and indirect neuroprotective effects, and also rapid vasoprotection, which occur independently of their cholesterol decreasing activity. Their unique properties have given to statins a place in contemporary therapy guidelines for treatment of the vascular RFs such as DL, arterial hypertension, coronary heart disease (CHD), diabetes mellitus and asymptomatic carotid stenosis in high risk patients. They are recommended for ischemic stroke (IS) primary and secondary prevention and prescribed for long periods. Statin vasoprotective and neuroprotective activities, which manifest immediately after administration, have raised discussion about their beneficial effect in acute IS, and in post-stroke recovery. The withdrawal of statin therapy worsens prognosis and increases mortality rate. There is evidence that oxidative stress and inflammation play role in depression and statin use decreases risk of depressive symptoms in CHD patients. Further well designed randomized studies are needed to investigate the efficacy and safety of statins in acute IS. A challenge for a new study on statins is clarifying whether they possess favorable effects on post-stroke depression in light of the new hypothesis of depression pathogenesis.
APA, Harvard, Vancouver, ISO, and other styles
48

Skoog, Ingmar. "Risk Factors for Vascular Dementia: A Review." Dementia and Geriatric Cognitive Disorders 5, no. 3-4 (1994): 137–44. http://dx.doi.org/10.1159/000106711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Anagnostopoulos, Alexia, Bruno Ledergerber, Stefan P. Kuster, Alexandra U. Scherrer, Bettina Näf, Reinhard Zbinden, Zoran Rancic, Dominique Bettex, Mario Lachat, and Barbara Hasse. "Risk Factors for Incident Vascular Graft Infections." Open Forum Infectious Diseases 4, suppl_1 (2017): S653. http://dx.doi.org/10.1093/ofid/ofx163.1740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Skoog, Ingmar. "Status of Risk Factors for Vascular Dementia." Neuroepidemiology 17, no. 1 (1998): 2–9. http://dx.doi.org/10.1159/000026147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography